阳性HPV头支状细胞癌:从分子病原体到治疗前沿
1Department of Pathology, Sanya Central Hospital (The Third People's Hospital of Hainan Province), Sanya, China.
The International journal of biological markers
|March 7, 2026
概括
人类乳头瘤病毒 (HPV) 阳性头角状细胞癌 (HNSCC) 是一种具有更好的结果的独特疾病. 研究重点是整合分子见解和缓解HPV阳性HNSCC的治疗.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 流行病学 流行病学
背景情况:
- 人类乳头瘤病毒 (HPV) 阳性头角状细胞癌 (HNSCC) 的全球发病率有所上升,改变了疾病流行病学.
- 与HPV阴性瘤相比,HPV阳性HNSCC是一种独特的实体,具有独特的分子特征,更好的治疗反应和更好的预后.
研究的目的:
- 审查HPV在HNSCC病变发生中的作用.
- 突出HPV阳性和HPV阴性HNSCC之间的流行病学,分子生物学和临床表现的差异.
- 检查目前和新兴的HPV阳性HNSCC的治疗方法.
主要方法:
- 关于HPV在HNSCC中的作用的文献综述.
- 对流行病学和分子差异的分析.
- 评估标准护理和新型治疗策略,包括降级和免疫治疗.
主要成果:
- 阳性HPV的HNSCC表现出不同的特征和更有利的预后.
- 降级策略旨在减少HPV阳性HNSCC治疗中的毒性.
- 免疫疗法和治疗性疫苗对复发性或转移性疾病有希望.
结论:
- 对于个性化管理HNSCC,HPV状态至关重要.
- 目前正在进行的研究和临床试验正在完善HPV阳性HNSCC的治疗策略.
- 了解和治疗HPV阳性HNSCC的进展正在改善患者的治疗结果.
更多相关视频
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
10.3K
06:57Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
11.4K
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cancer
55.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.2K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
